Abstract
Epidemiologic studies have adapted to the genomics era by forming large international consortia to overcome issues of large data volume and small sample size. Whereas both cohort and well-conducted case–control studies can inform disease risk from genetic susceptibility, cohort studies offer the additional advantages of assessing lifestyle and environmental exposure–disease time sequences often over a life course. Consortium involvement poses several logistical and ethical issues to investigators, some of which are unique to cohort studies, including the challenge to harmonize prospectively collected lifestyle and environmental exposures validly across individual studies. An open forum to discuss the opportunities and challenges of large-scale cohorts and their consortia was held in June 2009 in Banff, Canada, and is summarized in this report.
Similar content being viewed by others
References
Hoover RN (2007) The evolution of epidemiologic research: from cottage industry to “big” science. Epidemiology 18:13–17
Song H, Ramus SJ, Tyrer J et al (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41:996–1000
Milne RL, Benitez J, Nevanlinna H et al (2009) Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 101:1012–1018
National Cancer Institute. Cohort Consortium (2010) Available from http://epi.grants.cancer.gov/Consortia/cohort.html. Cited 2010
The Asian Cohort Consortium (2010) Available from http://www.asiacohort.org/Pages/Default.aspx. Cited 2010
Helzlsouer KJ (2010) Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172:4–9
Colditz GA (2010) Ensuring long-term sustainability of existing cohorts remains the highest priority to inform cancer prevention and control. Cancer Causes Control 21: 649–656
Borugian MJ, Robson P, Fortier I et al (2010) The Canadian partnership for tomorrow project: building a pan-Canadian research platform for disease prevention. CMAJ 182:1197–1201
UKM Medical Centre. Malaysia National Cohort (2010) Available from http://intra.hukm.ukm.my/. Cited 2010
Tehran University of Medical Sciences. Golestan Cohort Study of Esophageal Cancer (2010) Available from http://ddrc.tums.ac.ir/. Cited 2010
Oxford University. The Kadoorie Biobank Study in China (2010) Available from http://www.ctsu.ox.ac.uk/kadooriebiobank. Cited 2010
Jha P, Gajalakshmi V, Gupta PC et al (2006) Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med 3:e18
Christensen CM, Grossman JH, Hwang J (2008) The innovator’s prescription: a disruptive solution for health care. McGraw-Hill, New York
The P3G Observatory (2010) http://www.p3gobservatory.org. Cited 2010
Biobanking and Biomolecular Resources Research Infrastructure (2010) Available at http://www.bbmri.org. Cited 2010
International Society for Biological and Environmental Repositories (2010) Available at http://www.isber.org/FIBO.html. Cited 2010
UNESCO. International Declaration on Human Genetic Data (2010) Available at http://portal.unesco.org/en/ev.php-URL_ID=17720&URL_DO=DO_TOPIC&URL_SECTION=201.html. Cited 2010
Birney E, Hudson TJ, Green ED et al (2009) Prepublication data sharing. Nature 461:168–170
Bjorn G (2008) Barriers set up to protect genome databases. Nat Med 14:996
Homer N, Szelinger S, Redman M et al (2008) Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS genetics 4:e1000167
Lowrance WW, Collins FS (2007) Ethics. Identifiability in genomic research. Science 317:600–602
Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief funct genomics proteomics 6:193–201
Oosterhuis JW, Coebergh JW, van Veen EB (2003) Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer 3:73–77
O’Doherty KC, Burgess MM (2009) Engaging the public on biobanks: outcomes of the BC biobank deliberation. Public Health Genomics 12:203–215
Colditz GA, Winn DM (2008) Criteria for the evaluation of large cohort studies: an application to the nurses’ health study. J Natl Cancer Inst 100:918–925
Pourshams A, Khademi H, Malekshah AF et al (2010) Cohort profile: the Golestan cohort study–a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 39:52–59
Jha P, Jacob B, Gajalakshmi V et al (2008) A nationally representative case-control study of smoking and death in India. N Engl J Med 358:1137–1147
Brown RC, Dwyer T, Kasten C et al (2007) Cohort profile: the international childhood cancer cohort consortium (I4C). Int J Epidemiol 36:724–730
Olsen J, Melbye M, Olsen SF et al (2001) The Danish national birth cohort–its background, structure and aim. Scand J Public Health 29:300–307
Ronningen KS, Paltiel L, Meltzer HM et al (2006) The biobank of the Norwegian mother and child cohort study: a resource for the next 100 years. Eur J Epidemiol 21:619–625
Mertens AC, Liu Q, Neglia JP et al (2008) Cause-specific late mortality among 5-year survivors of childhood cancer: the childhood cancer survivor study. J Natl Cancer Inst 100:1368–1379
Robison LL, Armstrong GT, Boice JD et al (2009) The childhood cancer survivor study: a national cancer institute-supported resource for outcome and intervention research. J Clin Oncol 27:2308–2318
The Women’s Health Initiative Study Group (1998) Design of the women’s health initiative clinical trial and observational study. Control Clin Trials 19:61–109
Chlebowski RT, Kuller LH, Prentice RL et al (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360:573–587
Acknowledgments
The scientific and organizing committees would like to thank the conference speakers for their contributions: Paolo Boffetta, Graham Colditz, John Potter, Elio Riboli, Susan Hankinson, Laurence Kolonel, Michael Thun, Paula Robson, Rahman Jamal, Reza Malekzadeh, Zhengming Chen, Wei Zheng, Prabhat Jha, Daniela Seminara, Ellen Goode, Keun-Young Yoo, Paul Demers, Thomas Sellers, Isabel Fortier, Pierre Hainaut, Richard Gallagher, Jorn Olsen, Les Robison, Ross Prentice, Yutaka Yasui, Thomas Lumley, Kieran O’Doherty, Bartha Maria Knoppers, John McLaughlin, Louise Parker, John McPherson, Eric Paulos, and David Duggan. We gratefully acknowledge funding from the Canadian Partnership Against Cancer, the Canadian Institutes of Health Research, the Canadian Breast Cancer Research Alliance, the Canadian Cancer Society, Alberta Cancer Foundation/Alberta Cancer Research Institute, Alberta Heritage Foundation for Medical Research, and the University of Calgary.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Boffetta, P., Colditz, G.A., Potter, J.D. et al. Cohorts and consortia conference: a summary report (Banff, Canada, June 17–19, 2009). Cancer Causes Control 22, 463–468 (2011). https://doi.org/10.1007/s10552-010-9717-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-010-9717-0